Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 7 (July)

1. Does the Child Behavior Checklist juvenile bipolar disorder phenotype identify bipolar disorder?
   Biol Psychiatry, 62(2): 115-20. [Abstract] [Full-text]
2. Affective neural circuitry during facial emotion processing in pediatric bipolar disorder.
   Biol Psychiatry, 62(2): 158-67. [Abstract] [Full-text]
3. Neuropsychological functioning in bipolar disorder and schizophrenia.
   Biol Psychiatry, 62(2): 179-86. [Abstract] [Full-text]
4. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?
   Biol Psychiatry, 62(2): 135-40. [Abstract] [Full-text]
5. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives.
   Biol Psychiatry, 62(2): 121-8. [Abstract] [Full-text]
6. Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004.
   Biol Psychiatry, 62(2): 107-14. [Abstract] [Full-text]
7. Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
   Biopharm Drug Dispos, 28(5): 249-56. [Abstract] [Full-text]
8. Lithium-pilocarpine seizures as a model for lithium action in mania.
   Neurosci Biobehav Rev. [Abstract] [Full-text]
9. Treatment for Co-occurring Mental and Substance Use Disorders in Five State Medicaid Programs.
   Psychiatr Serv, 58(7): 942-8. [Abstract] [Full-text]
10. Light exposure, melatonin secretion, and menstrual cycle parameters: an integrative review.
    Biol Res Nurs, 9(1): 49-69. [Abstract] [Full-text]
11. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.
    Clin Pract Epidemol Ment Health, 3: 5. [Abstract] [Full-text]
12. Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder.
    Biol Psychiatry, 62(2): 129-34. [Abstract] [Full-text]
13. Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder.
    Biol Psychiatry, 62(2): 141-7. [Abstract] [Full-text]
14. Bipolar affective puerperal psychosis: genome-wide significant evidence for linkage to chromosome 16.
    Am J Psychiatry, 164(7): 1099-104. [Abstract] [Full-text]
15. Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms.
    Schizophr Bull, 33(4): 932-6. [Abstract] [Full-text]
16. Identifying Functional Neuroimaging Biomarkers of Bipolar Disorder: Toward DSM-V.
    Schizophr Bull, 33(4): 893-904. [Abstract] [Full-text]
17. The neuropharmacology of psychosis.
    Schizophr Bull, 33(4): 937-46. [Abstract] [Full-text]
18. Deconstructing Bipolar Disorder: A Critical Review of its Diagnostic Validity and a Proposal for DSM-V and ICD-11.
    Schizophr Bull, 33(4): 886-92. [Abstract] [Full-text]
19. DSM-V Research Agenda: Substance Abuse/Psychosis Comorbidity.
    Schizophr Bull, 33(4): 947-52. [Abstract] [Full-text]
20. The genetic deconstruction of psychosis.
    Schizophr Bull, 33(4): 905-11. [Abstract] [Full-text]
21. Deconstructing psychosis with human brain imaging.
    Schizophr Bull, 33(4): 921-31. [Abstract] [Full-text]
22. Are behavioral problems in childhood and adolescence associated with bipolar disorder in early adulthood?
    Eur Arch Psychiatry Clin Neurosci, 257(4): 217-21. [Abstract] [Full-text]
23. Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets.
    Hum Psychopharmacol, 22(5): 307-14. [Abstract] [Full-text]
24. Off-label prescription of quetiapine in psychiatric disorders.
    Expert Rev Neurother, 7(7): 841-52. [Abstract] [Full-text]
25. Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan.
    Psychiatry Clin Neurosci, 61(4): 428-33. [Abstract] [Full-text]
26. Convergent Functional Genomics of bipolar disorder: From animal model pharmacogenomics to human genetics and biomarkers.
    Neurosci Biobehav Rev. [Abstract] [Full-text]
27. A closer look: the benefits and effectiveness of cognitive behavioral therapy on a female-specific unit for treatment of bipolar disorder.
    Issues Ment Health Nurs, 28(5): 533-42. [Abstract] [Full-text]
28. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Clin Ther, 29(4): 723-41. [Abstract] [Full-text]
29. Analysis Of TBX1 Variation In Patients With Psychotic And Affective Disorders.
    Mol Med. [Abstract] [Full-text]
30. Probing genetic overlap among complex human phenotypes.
    Proc Natl Acad Sci U S A, 104(28): 11694-9. [Abstract] [Full-text]
31. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?
    Addiction, 102(8): 1251-60. [Abstract] [Full-text]
32. Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement.
    Neurosci Biobehav Rev. [Abstract] [Full-text]
33. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.
    CNS Drug Rev, 13(2): 137-77. [Abstract] [Full-text]
34. Problem gambling in bipolar disorder: results from the Canadian Community Health Survey.
    J Affect Disord, 102(1): 27-34. [Abstract] [Full-text]
35. Comorbid disorders in patients with bipolar disorder and concomitant substance dependence.
    J Affect Disord, 102(1): 281-7. [Abstract] [Full-text]
36. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
    J Affect Disord, 102(1): 145-51. [Abstract] [Full-text]
37. Psychopathology in children of bipolar parents.
    J Affect Disord, 102(1): 131-6. [Abstract] [Full-text]
38. Tryptophan breakdown pathway in bipolar mania.
    J Affect Disord, 102(1): 65-72. [Abstract] [Full-text]
39. A comparative study on dual patients with affective disorder.
    J Affect Disord, 102(1): 109-14. [Abstract] [Full-text]
40. Fertility and childhood bipolar disorder.
    Med Hypotheses, 69(3): 587-9. [Abstract] [Full-text]
41. Is Oppositional Defiant Disorder a Meaningful Diagnosis in Adults?: Results From a Large Sample of Adults With ADHD.
    J Nerv Ment Dis, 195(7): 601-605. [Abstract] [Full-text]
42. A functional MRI study of a paced motor activation task to evaluate frontal-subcortical circuit function in bipolar depression.
    Psychiatry Res, 155(3): 221-30. [Abstract] [Full-text]
43. Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders.
    Schizophr Res, 94(1): 273-80. [Abstract] [Full-text]
44. Polyphosphoinositol lipids: under-PPInning synaptic function in health and disease.
    Dev Neurobiol, 67(9): 1232-47. [Abstract] [Full-text]
45. Quetiapine prevents anhedonia induced by acute or chronic stress.
    Neuropsychopharmacology, 32(8): 1783-90. [Abstract] [Full-text]
46. Serial vagus nerve stimulation functional MRI in treatment-resistant depression.
    Neuropsychopharmacology, 32(8): 1649-60. [Abstract] [Full-text]
47. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
    Neuropsychopharmacology, 32(8): 1727-37. [Abstract] [Full-text]
48. Protein Kinase C Inhibition by Tamoxifen Antagonizes Manic-Like Behavior in Rats: Implications for the Development of Novel Therapeutics for Bipolar Disorder.
    Neuropsychobiology, 55(3): 123-131. [Abstract] [Full-text]
49. Lithium-induced nephrogenic diabetes insipidus after coronary artery bypass.
    Ann Thorac Surg, 84(2): 656-7. [Abstract] [Full-text]
50. Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions.
    Neuroscientist, 13(4): 392-404. [Abstract] [Full-text]
51. Expression of CB(1) cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression.
    J Neural Transm, 114(8): 1055-63. [Abstract] [Full-text]
52. Is the volume-outcome relationship sustained in psychiatric care?
    Soc Psychiatry Psychiatr Epidemiol, 42(8): 669-72. [Abstract] [Full-text]
53. How do General Practitioners experience providing care for their psychotic patients?
    BMC Fam Pract, 8: 37. [Abstract] [Full-text]
54. Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(6): 1182-8. [Abstract] [Full-text]
55. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(6): 1219-23. [Abstract] [Full-text]
56. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(6): 1177-81. [Abstract] [Full-text]
57. Examining ventral and dorsal prefrontal function in bipolar disorder: A functional magnetic resonance imaging study.
    Eur Psychiatry. [Abstract] [Full-text]
58. NO synthase-positive striatal interneurons are decreased in schizophrenia.
    Eur Neuropsychopharmacol, 17(9): 595-9. [Abstract] [Full-text]
59. Role of the COMT gene Val158Met polymorphism in mental disorders: A review.
    Eur Psychiatry, 22(5): 276-81. [Abstract] [Full-text]
60. A gastrin-releasing peptide receptor antagonist blocks d-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats.
    Peptides, 28(7): 1447-1452. [Abstract] [Full-text]
61. Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
    Bioorg Med Chem Lett, 17(16): 4491-4. [Abstract] [Full-text]
62. Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder.
    Eur Psychiatry, 22(5): 282-7. [Abstract] [Full-text]
63. The relationship of personality traits to substance abuse in patients with bipolar disorder.
    Eur Psychiatry, 22(5): 305-8. [Abstract] [Full-text]
64. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder.
    Psychopharmacology (Berl), 193(4): 467-74. [Abstract] [Full-text]
65. Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature.
    Epilepsy Behav, 11(1): 133-9. [Abstract] [Full-text]
66. The role of vascular risk factors in late onset bipolar disorder.
    Int J Geriatr Psychiatry, 22(8): 733-7. [Abstract] [Full-text]
67. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
    Psychiatr Serv, 58(8): 1073-8. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.